Author

Haylye White

Institution: Mayo Clinic

Observed institutions: Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic Hospital

OpenAlex ID: A5067992249

Shape matters: morphological metrics of glioblastoma imaging abnormalities as biomarkers of prognosis

2021 · Lee Curtin, Paula Whitmire, et al. · Scientific Reports · 31

Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma

2020 · Susan Christine Massey, Haylye White, et al. · PLoS ONE · 15

Ncog-69. Sex Differences in Glioblastoma Patient Survival as a Function of Extent of Surgical Resection and Cycles of Adjuvant Temozolomide During Standard-of-care Regimens

2020 · Julia Lorence, Tomas Bencomo, et al. · Neuro-Oncology · 2

Morphological Metrics of Magnetic Resonance Imaging of Glioblastoma as Biomarkers of Prognosis

2021 · Lee Curtin, Paula Whitmire, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Nimg-64. Impact of Tumor Location on Image-derived Volume, Proliferation Rate and Growth Velocity in Glioblastoma Patients

2019 · Julia Lorence, Kristin Swanson, et al. · Neuro-Oncology

Nimg-07. Lacunarity and Fractal Dimension Act as Pretreatment Imaging Biomarkers for Survival in Glioblastoma Patients

2019 · Lee Curtin, Paula Whitmire, et al. · Neuro-Oncology

Nimg-16. Impact of Sex Differences and Tumor Location on Survival Outcomes in Glioblastoma Patients

2018 · Julia Lorence, Susan Christine Massey, et al. · Neuro-Oncology

Tmod-38. Extent of Glioblastoma Invasion Predicts Overall Survival Following Upfront Radiotherapy Concurrent With Temozolomide

2017 · Susan Christine Massey, Haylye White, et al. · Neuro-Oncology

Works count: 8

Citation count: 48

H-index: 2

I10-index: 2